logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Solid Olodaterol CAS 868049-49-4 813-858-3

Solid Olodaterol CAS 868049-49-4 813-858-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 868049-49-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

Olodaterol CAS 868049-49-4

,

Olodaterol 813-858-3

CAS NO::
868049-49-4
Appearance::
Solid
Molecular Formula::
C21H26N2O5
Molecular Weight::
386.44200
EINECS NO::
813-858-3
MDL NO::
NA
CAS NO::
868049-49-4
Appearance::
Solid
Molecular Formula::
C21H26N2O5
Molecular Weight::
386.44200
EINECS NO::
813-858-3
MDL NO::
NA
Solid Olodaterol CAS 868049-49-4 813-858-3

Product Description:

Product Name: olodaterol CAS NO: 868049-49-4

 

 

Synonyms:

6-hydroxy-8-[(1R)-1-hydroxy-2-[[1-(4-methoxyphen-yl)-2-methylpropan-2-yl]amino]ethyl]-4H-1,4-benzoxazin-3-one;

2H-1,4-Benzoxazin-3(4H)-one,6-hydroxy-8-[(1R)-1-hydroxy-2-[[2-(4-methoxyphen-yl)-1,1-dimethylethyl]amino]ethyl]-;

 

 

Chemical & Physical Properties:

Appearance: Solid

Assay :≥99.0%

Density: 1.250g/cm3

Boiling Point: 649.05℃ at 760 mmHg

Flash Point: 346.333℃

Vapor Pressure: 0.0±2.0 mmHg at 25℃

Index of Refraction: 1.596

 

 

Olodaterol (trade name Striverdi Respimat STRIH-ver-dee-RES-peh-mat) is an ultra-long-acting β adrenoreceptor agonist (ultra-LABA) used as an inhalation for treating patients with chronic obstructive pulmonary disease (COPD), manufactured by Boehringer Ingelheim. A member of the class of benzoxazine that is 6-hydroxy-1,4-benzoxazin-3-one in which the hydrogen at position 4 is replaced by a (1R)-1-hydroxy-2-{[1-(4-methoxyphen-yl)-2-methylpropan-2-yl]amino}ethyl group. Used (as its hydrochloride salt) for long-term treatment of airflow obstruction in patients with chronic obstructive pulmonary disease including chronic bronchitis and/or emphysema.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.